| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |